EMA Committee Recommends Approval of Opdivo® + Yervoy® for First-Line Treatment of MSI-H/dMMR Metastatic Colorectal Cancer

 Bristol Myers Squibb (NYSE: BMY) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...

November 18, 2024 | Monday | News
BioNTech Acquires Biotheus to Strengthen Oncology Pipeline with Bispecific Antibody Asset BNT327/PM8002

BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Biotheus (“Biotheus”) announced the signing of a definitive agreement for...

November 14, 2024 | Thursday | News
TAE Life Sciences and Stella Pharma Announce Exclusive Collaboration to Expand BNCT Therapy in the U.S. and Europe

TAE Life Sciences (TLS), a leader in boron neutron capture therapy (BNCT) technology, and Stella Pharma, the pioneering developer of the boronophenylalan...

November 14, 2024 | Thursday | News
Exact Sciences to Present Key Findings on Multi-Cancer Early Detection Test at AACR Conference in San Diego

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, will present three abstracts highlighting significant adv...

November 14, 2024 | Thursday | News
Ontada and Datavant Forge Strategic Collaboration to Accelerate Oncology Innovation Through Real-World Data Integration

 Ontada®, a McKesson business and leader in community oncology real-world data, clinical education, and point of care technologies, has ...

November 13, 2024 | Wednesday | News
Bio-Rad Advances Oncology Diagnostics with IVDR Certification for CML Assay and Strategic Collaborations in MRD and ctDNA Detection

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced updates on its onco...

November 13, 2024 | Wednesday | News
New Survey Reveals Critical Gaps in Care for Gynaecologic Cancer Patients, Highlighting Unmet Needs in Treatment Access and Support

GSK plc (LSE/NYSE: GSK) announced the results of a GSK-sponsored multinational survey designed to raise awareness of challenges that people with gynaecolog...

November 13, 2024 | Wednesday | News
Alteogen and Daiichi Sankyo Partner to Develop Subcutaneous ENHERTU® Using Novel Hyaluronidase Technology

Alteogen Inc. (KOSDAQ:196170) announced that the company has entered into an exclusive license agreement with Daiichi Sankyo (TSE: 4568). Under the terms o...

November 11, 2024 | Monday | News
Fate Therapeutics Unveils Promising Preclinical Data for FT836, a Next-Generation iPSC-Derived CAR T-Cell Therapy Targeting MICA/B at SITC 2024

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripot...

November 12, 2024 | Tuesday | News
Dragonfly Therapeutics to Present Groundbreaking Preclinical Data on DF6215 and DF9001 at SITC 2024

 a clinical-stage biotechnology company developing novel immunotherapies, announced the company will deliver poster presentations at the Society for I...

November 08, 2024 | Friday | News
AstraZeneca Unveils Pioneering Haematology Research at ASH 2024, Highlighting Advancements in Cancer and Rare Disease Treatments

AstraZeneca advances its ambition to redefine cancer care with new data across its industry-leading and diverse pipeline in haematology at the 66th Am...

November 08, 2024 | Friday | News
Agilent Technologies Honors Professors Isabelle Plante and Bangyan Stiles with Solutions Innovation Research Awards for Cell and Gene Therapy Research

Agilent Technologies Inc. (NYSE: A) announced that Professor Isabelle Plante at Institut National de la Recherche Scientifique (INRS), and&n...

November 07, 2024 | Thursday | News
Poseida Therapeutics to Present New Preclinical Data and Clinical Insights at SITC and ASH 2024

Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral t...

November 06, 2024 | Wednesday | News
Bionomics Secures AUS$1M Milestone Payment from Carina Biotech for Progress in Australia’s Oncology Program

Bionomics , a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from s...

November 05, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close